Circulating tumor DNA-based molecular residual disease detection for the monitoring of high-grade serous ovarian cancer.
Xiangxian Ying(Zhejiang University of Technology), Xipeng Wang(Shanghai Jiao Tong University), Xiaocui Zheng(XinHua Hospital), Yizhi Wang(Northwestern University), Xing Li(Xinjiang Medical University), Jiarui Li(Nanjing University of Chinese Medicine), Kai Wang(Michigan United), Guomin Lin
Cited by 1
Related Papers
The MicroRNA Spectrum in 12 Body Fluids
|Clinical Chemistry|2010|2.8k
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci
|Nature Genetics|2010|2.6k
Comparison and integration of deleteriousness prediction methods for nonsynonymous SNVs in whole exome sequencing studies
|Human Molecular Genetics|2014|1.2k
Reduced default mode network functional connectivity in patients with recurrent major depressive disorder
|Proceedings of the National Academy of Sciences|2019|865
Common variants at five new loci associated with early-onset inflammatory bowel disease
|Nature Genetics|2009|483